Cognitive Remediation VR Tool for People With MCI: a Feasibility RCT

Launched by UNIVERSITY OF CAGLIARI · Feb 13, 2024

Keywords

ClinConnect Summary

This clinical trial is exploring a new way to help people with Mild Cognitive Impairment (MCI) using virtual reality (VR) technology. The goal is to see if this immersive VR tool can improve cognitive function, which includes things like memory and thinking skills. The study is part of a broader effort to promote healthy aging through innovative methods. While the trial is not yet recruiting participants, it aims to learn more about how effective this approach could be for individuals aged 65 and older who have been diagnosed with MCI.

To join the study, participants need to be at least 65 years old and have a diagnosis of MCI. However, those with certain health conditions, such as epilepsy or severe visual problems, will not be eligible due to potential risks from using VR. If you or a loved one meets the criteria and chooses to participate, you can expect to engage in bi-weekly VR sessions designed to help improve cognitive abilities. This trial represents an exciting opportunity to explore new ways to support brain health in older adults.

Gender

ALL

Eligibility criteria

• Inclusion Criteria:
• • age 65 and above, a diagnosis of MCI based on DSM-IV criteria \[American Psychiatric Association, 2000\]
• Exclusion Criteria:
• • failure to meet inclusion criteria, a diagnosis of epilepsy or severe visual impairments due to potential risks associated with extensive virtual reality stimulation, and severe illnesses impeding bi-weekly intervention attendance